Jay O. Boyle
- Otorhinolaryngology top 0.1%
- Head and Neck Cancer Studies 20
- Oncology top 1%
- Cancer-related Molecular Pathways 9
- Cancer Diagnosis and Treatment 7
- Periodontics top 0.5%
- Cancer Research top 1%
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects 13
-
- Head and Neck Surgical Oncology 10
- Reconstructive Surgery and Microvascular Techniques 6
-
- Estrogen and related hormone effects 10
-
- Eicosanoids and Hypertension Pharmacology 5
- Co-authors
- Jatin P. ShahDavid SidranskyRalph H. HrubanAndrew J. DannenbergWayne M. KochYolanda EbyKotha SubbaramaiahDennis H. Kraus
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Jay O. Boyle
64 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Otorhinolaryngology 1.8k
- Oncology 2.5k
- Periodontics 414
- Cancer Research 1.1k
- Pharmacology 1.1k
Countries citing papers authored by Jay O. Boyle
This map shows the geographic impact of Jay O. Boyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay O. Boyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay O. Boyle more than expected).
Fields of papers citing papers by Jay O. Boyle
This network shows the impact of papers produced by Jay O. Boyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay O. Boyle. The network helps show where Jay O. Boyle may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jay O. Boyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2013 | 20 | |
| 4 | 2010 | 125 | |
| 5 | 2008 | 49 | |
| 6 | 2006 | 123 | |
| 7 | 2006 | 18 | |
| 8 | 2005 | 86 | |
| 9 | Gefitinib (’Iressa’, ZD1839) inhibits the expression of COX-2 and the growth of experimental head and neck squamous-cell carcinoma | 2004 | 2 |
| 10 | 2004 | 97 | |
| 11 | 2003 | 47 | |
| 12 | 2002 | 228 | |
| 13 | 2002 | 172 | |
| 14 | 2001 | 409 | |
| 15 | 2001 | 10 | |
| 16 | 1999 | 84 | |
| 17 | 1998 | 52 | |
| 18 | Association between Cigarette Smoking and Mutation of the p53 Gene in Squamous-Cell Carcinoma of the Head and Neckbreakdown → | 1995 | 506 |
| 19 | 1994 | 42 | |
| 20 | 1988 | 9 |
About Jay O. Boyle
Jay O. Boyle is a scholar working on Otorhinolaryngology, Oncology, Pharmacology, Biochemistry and Periodontics, having authored 65 papers that have together received 6.6k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (20 papers), Inflammatory mediators and NSAID effects (13 papers), Head and Neck Surgical Oncology (10 papers), Estrogen and related hormone effects (10 papers), Cancer-related Molecular Pathways (9 papers), Cancer Diagnosis and Treatment (7 papers), Reconstructive Surgery and Microvascular Techniques (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). The work is most often cited by research in Otorhinolaryngology (1.8k citations), Oncology (2.5k citations), Periodontics (414 citations), Cancer Research (1.1k citations) and Pharmacology (1.1k citations). Jay O. Boyle has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Jatin P. Shah, David Sidransky, Ralph H. Hruban, Andrew J. Dannenberg, Wayne M. Koch, Yolanda Eby, Kotha Subbaramaiah, Dennis H. Kraus, Bhuvanesh Singh and Ashok R. Shaha. Their work appears in journals such as Cancer Prevention Research, Cancer, Head & Neck, Clinical Cancer Research and Oral Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.